Informations générales (source: ClinicalTrials.gov)
A Case Control Study on Contribution to the Analysis of the Phenotypic Heterogeneity in Crack/Cocaine Addiction (CRACK-ANT)
Interventional
N/A
University Hospital Center of Martinique (Voir sur ClinicalTrials)
décembre 2009
décembre 2012
29 juin 2024
The purpose of this study is to assess the phenotypic candidates symptoms, in patients
with crack/cocaine addiction, in terms of clinical comorbidities, dimensions of
personality, and neuropsychological evaluations apt to be associated with genetic and
genotypic characterisations, notably on the polymorphisms of the genes coding or
regulating dopaminergic, norepinephrine and serotoninergic systems.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Service de psychiatrie et addictologie - CHU de Fort-de-France - 97261 - Fort-de-France - Martinique - France | Jocelyne CRASPAG, Master | Contact (sur clinicalTrials) | |||
Critères
Homme
Inclusion Criteria:
- Diagnosis of cocaine abuse/dependence according to DSM-IV-TR criteria
- Come from French West Indies (3 grandparents are African-Caribbean)
- Sign a written informed consent
- Diagnosis of cocaine abuse/dependence according to DSM-IV-TR criteria
- Come from French West Indies (3 grandparents are African-Caribbean)
- Sign a written informed consent
- Minor
- Men with no cocaine abuse/dependence according to DSM-IV-TR criteria
For the control:
Inclusion Criteria:
- Platelets donor
- No substance abuse/dependence according to DSM-IV-TR criteria
- Come from French West Indies (3 grandparents are African-Caribbean)
- Sign a written informed consent
Exclusion Criteria:
- Minor
- Men refusing a genetic study